Binding affinity to the antiapoptotic protein Bcl-xL: Ki = 7.6 μM. In vitro cytotoxic activity towards KB cells: IC50 = 15 μM; HCT-116 colon cancer cells: IC50 = 5.8 μM; MCF7 cells: IC50 = 11.3; L1210 lymphocytic leukemia cells: IC50 = 6.8 μM; HL-60 human promyelocytic leukemia cells (JCRB0085): IC50 = 34.2 ± 0.7 μM. In vitro protein tyrosine phosphatase inhibition assay: IC50 = 11 μM. In vitro anti-inflammatory activity (inhibition of LPS-induced NO production in BV-2 cells): IC50 > 3 μM. DPPH radical scavenging activity: IC50 = 169.7 μg/mL. The gene discussed is BCL2L1; the disease is lymphoid leukemia.